Biosafety risks are of concern for some of these tests. Based on a large body of ... for the rapid screening of patients at risk of MDR-TB. This was extended to 27 countries in May 2009 by UNITAID.
India accounts for 30% of the global TB burden and 62% of multidrug-resistant cases. Despite a 17.7% reduction in incidence ...
Mumbai: Although the Centre's aim to eliminate tuberculosis (TB) by the end of 2025 seems unlikely, the BMC, on the eve of ...
The BPaLM regimen promises a breakthrough in MDR-TB treatment with a shorter, all-oral approach. However, high costs, limited ...
"These districts have surpassed 100 per cent screening coverage among vulnerable populations," said Dr A Rajesham, Joint ...
Background: The tuberculosis burden in children exposed at home to multidrug-resistant tuberculosis (MDR-TB) is unquantified. With limited access to MDR-TB treatment, likely millions of children ...
Under the BioVersys and GSK collaboration agreement, GSK is evaluating the early bactericidal activity (EBA) of alpibectir-ethionamide (AlpE) in a pulmonary tuberculosis (TB) trial, in combination ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback